Baolingbao Biology Co.,Ltd. (SHE:002286)
China
· Delayed Price · Currency is CNY 10.17
-0.01 (-0.10%)
Apr 29, 2026, 3:04 PM CST
Baolingbao Biology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,814 | 2,751 | 2,392 | 2,516 | 2,713 | 2,755 | Upgrade
|
| Other Revenue | - | - | 9.46 | 7.65 | - | 9.9 | Upgrade
|
| Revenue | 2,814 | 2,751 | 2,402 | 2,524 | 2,713 | 2,765 | Upgrade
|
| Revenue Growth (YoY) | 10.99% | 14.54% | -4.84% | -6.96% | -1.89% | 34.58% | Upgrade
|
| Cost of Revenue | 2,427 | 2,386 | 2,123 | 2,326 | 2,404 | 2,397 | Upgrade
|
| Gross Profit | 386.83 | 364.72 | 278.47 | 197.52 | 308.4 | 368.24 | Upgrade
|
| Selling, General & Admin | 168.62 | 156.42 | 106.05 | 106.5 | 129.8 | 122.17 | Upgrade
|
| Research & Development | 20.8 | 13.78 | 9.54 | 11.3 | 8.46 | 12.58 | Upgrade
|
| Other Operating Expenses | -1.95 | 5.72 | 15.66 | 15.74 | 15.95 | 16.33 | Upgrade
|
| Operating Expenses | 187.46 | 175.92 | 134.77 | 137.74 | 151.82 | 155.21 | Upgrade
|
| Operating Income | 199.37 | 188.8 | 143.7 | 59.78 | 156.58 | 213.03 | Upgrade
|
| Interest Expense | - | - | -13.04 | -22.68 | -26.54 | -16.95 | Upgrade
|
| Interest & Investment Income | 1.96 | 1.96 | 6.9 | 7.36 | 7.97 | 18.85 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 6.64 | 1.61 | 12.17 | -4.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -16.08 | -9.55 | 1.92 | -3.09 | -1.53 | 0.92 | Upgrade
|
| EBT Excluding Unusual Items | 186.28 | 181.21 | 146.12 | 42.98 | 148.65 | 211.58 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 2.61 | 11.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.41 | -0.05 | -0.05 | - | Upgrade
|
| Asset Writedown | -3.35 | -3.4 | -22.56 | 0.01 | -2.32 | 0.83 | Upgrade
|
| Other Unusual Items | - | - | 7.15 | 22.17 | 7.79 | 13.09 | Upgrade
|
| Pretax Income | 182.93 | 177.81 | 131.11 | 65.11 | 156.69 | 236.74 | Upgrade
|
| Income Tax Expense | 28.52 | 27.18 | 19.95 | 11.15 | 23.52 | 35.16 | Upgrade
|
| Earnings From Continuing Operations | 154.4 | 150.63 | 111.16 | 53.97 | 133.17 | 201.58 | Upgrade
|
| Net Income | 154.4 | 150.63 | 111.16 | 53.97 | 133.17 | 201.58 | Upgrade
|
| Net Income to Common | 154.4 | 150.63 | 111.16 | 53.97 | 133.17 | 201.58 | Upgrade
|
| Net Income Growth | 11.61% | 35.50% | 105.97% | -59.47% | -33.94% | 304.27% | Upgrade
|
| Shares Outstanding (Basic) | 374 | 367 | 371 | 360 | 370 | 373 | Upgrade
|
| Shares Outstanding (Diluted) | 374 | 367 | 371 | 360 | 370 | 373 | Upgrade
|
| Shares Change (YoY) | 2.80% | -0.85% | 2.99% | -2.74% | -0.91% | 4.81% | Upgrade
|
| EPS (Basic) | 0.41 | 0.41 | 0.30 | 0.15 | 0.36 | 0.54 | Upgrade
|
| EPS (Diluted) | 0.41 | 0.41 | 0.30 | 0.15 | 0.36 | 0.54 | Upgrade
|
| EPS Growth | 8.56% | 36.67% | 100.00% | -58.33% | -33.33% | 285.71% | Upgrade
|
| Free Cash Flow | 56.63 | 70.07 | 58.79 | 130.05 | -223.72 | 113.42 | Upgrade
|
| Free Cash Flow Per Share | 0.15 | 0.19 | 0.16 | 0.36 | -0.60 | 0.30 | Upgrade
|
| Dividend Per Share | - | - | 0.095 | 0.080 | 0.080 | 0.060 | Upgrade
|
| Dividend Growth | - | - | 18.75% | - | 33.33% | - | Upgrade
|
| Gross Margin | 13.75% | 13.26% | 11.59% | 7.83% | 11.37% | 13.32% | Upgrade
|
| Operating Margin | 7.08% | 6.86% | 5.98% | 2.37% | 5.77% | 7.70% | Upgrade
|
| Profit Margin | 5.49% | 5.47% | 4.63% | 2.14% | 4.91% | 7.29% | Upgrade
|
| Free Cash Flow Margin | 2.01% | 2.55% | 2.45% | 5.15% | -8.25% | 4.10% | Upgrade
|
| EBITDA | 317.87 | 307.23 | 261.84 | 177.62 | 258.01 | 318.01 | Upgrade
|
| EBITDA Margin | 11.30% | 11.17% | 10.90% | 7.04% | 9.51% | 11.50% | Upgrade
|
| D&A For EBITDA | 118.5 | 118.43 | 118.14 | 117.84 | 101.43 | 104.98 | Upgrade
|
| EBIT | 199.37 | 188.8 | 143.7 | 59.78 | 156.58 | 213.03 | Upgrade
|
| EBIT Margin | 7.08% | 6.86% | 5.98% | 2.37% | 5.77% | 7.70% | Upgrade
|
| Effective Tax Rate | 15.59% | 15.29% | 15.22% | 17.12% | 15.01% | 14.85% | Upgrade
|
| Revenue as Reported | - | - | 2,402 | 2,524 | 2,713 | 2,765 | Upgrade
|
| Advertising Expenses | - | - | 1.87 | 2.62 | 2.64 | 1.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.